Literature DB >> 8394845

Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts.

P Lenormand1, C Sardet, G Pagès, G L'Allemain, A Brunet, J Pouysségur.   

Abstract

Mitogen-activated protein kinases (p42mapk and p44mapk) are serine/threonine kinases that are activated rapidly in cells stimulated with various extracellular signals. This activation is mediated via MAP kinase kinase (p45mapkk), a dual specificity kinase which phosphorylates two key regulatory threonine and tyrosine residues of MAP kinases. We reported previously that the persistent phase of MAP kinase activation is essential for mitogenically stimulated cells to pass the "restriction point" of the cell cycle. Here, using specific polyclonal antibodies and transfection of epitope-tagged recombinant MAP kinases we demonstrate that these signaling protein kinases undergo distinct spatio-temporal localization in growth factor-stimulated cells. In G0-arrested hamster fibroblasts the activator p45mapkk and MAP kinases (p42mapk, p44mapk) are mainly cytoplasmic. Subsequent to mitogenic stimulation by serum or alpha-thrombin both MAP kinase isoforms translocate into the nucleus. This translocation is rapid (seen in 15 min), persistent (at least during the entire G1 period up to 6 h), reversible (by removal of the mitogenic stimulus) and apparently 'coupled' to the mitogenic potential; it does not occur in response to nonmitogenic agents such as alpha-thrombin-receptor synthetic peptides and phorbol esters that fail to activate MAP kinases persistently. When p42mapk and p44mapk are expressed stably at high levels, they are found in the nucleus of resting cells; this nuclear localization is also apparent with kinase-deficient mutants (p44mapk T192A or Y194F). In marked contrast the p45mapkk activator remains cytoplasmic even during prolonged growth factor stimulation and even after high expression levels achieved by transfection. We propose that the rapid and persistent nuclear transfer of p42mapk and p44mapk during the entire G0-G1 period is crucial for the function of these kinases in mediating the growth response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394845      PMCID: PMC2119624          DOI: 10.1083/jcb.122.5.1079

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  42 in total

Review 1.  Transmembrane receptors and intracellular pathways that control cell proliferation.

Authors:  J Pouysségur; K Seuwen
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

2.  Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity.

Authors:  S Meloche; K Seuwen; G Pagès; J Pouysségur
Journal:  Mol Endocrinol       Date:  1992-05

Review 3.  Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6.

Authors:  T W Sturgill; J Wu
Journal:  Biochim Biophys Acta       Date:  1991-05-17

4.  Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist.

Authors:  V Vouret-Craviari; E Van Obberghen-Schilling; J C Scimeca; E Van Obberghen; J Pouysségur
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

5.  Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase.

Authors:  N G Ahn; R Seger; R L Bratlien; C D Diltz; N K Tonks; E G Krebs
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

6.  Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669.

Authors:  I C Northwood; F A Gonzalez; M Wartmann; D L Raden; R J Davis
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

7.  Immunological characterization of avian MAP kinases: evidence for nuclear localization.

Authors:  J S Sanghera; M Peter; E A Nigg; S L Pelech
Journal:  Mol Biol Cell       Date:  1992-07       Impact factor: 4.138

8.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro.

Authors:  P Dent; W Haser; T A Haystead; L A Vincent; T M Roberts; T W Sturgill
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

9.  A protein kinase gene complements the lytic phenotype of Saccharomyces cerevisiae lyt2 mutants.

Authors:  L Torres; H Martín; M I García-Saez; J Arroyo; M Molina; M Sánchez; C Nombela
Journal:  Mol Microbiol       Date:  1991-11       Impact factor: 3.501

10.  Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo.

Authors:  L B Ray; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  179 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 2.  Cardiac signal transduction.

Authors:  K H Lee; R J Hajjar; T Matsui; G Choukroun; T L Force; A Rosenzweig
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 3.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

4.  Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.

Authors:  S T Eblen; A D Catling; M C Assanah; M J Weber
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 5.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Characterization of Fus3 localization: active Fus3 localizes in complexes of varying size and specific activity.

Authors:  K Y Choi; J E Kranz; S K Mahanty; K S Park; E A Elion
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

7.  Functional proteomic analysis of human nucleolus.

Authors:  Alexander Scherl; Yohann Couté; Catherine Déon; Aleth Callé; Karine Kindbeiter; Jean-Charles Sanchez; Anna Greco; Denis Hochstrasser; Jean-Jacques Diaz
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

8.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 9.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

10.  MMK2, a novel alfalfa MAP kinase, specifically complements the yeast MPK1 function.

Authors:  C Jonak; S Kiegerl; C Lloyd; J Chan; H Hirt
Journal:  Mol Gen Genet       Date:  1995-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.